Management of ERCP Failure in Malignant Biliary Obstruction: Comparative Effectiveness and Safety of EUS-Guided Gallbladder Drainage Versus Choledocoduodenostomy.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mangiavillano Benedetto, Franchellucci Gianluca, Auriemma Francesco, Ramai Daryl, Fugazza Alessandro, Spadaccini Marco, Barbera Carmelo, Vanella Giuseppe, De Nucci Germana, Fuller Andrew, Martínez-Moreno Belén, Di Mitri Roberto, Di Matteo Francesco, Medranda Carlos Robles, Anderloni Andrea, De Luca Luca, Teoh Anthony Yuen Bun, Vargas-Madrigal Jorge, Forti Edoardo, Bronswijk Michiel, Mangiafico Santi, Bertani Helga, Lakhtakia Sundeep, Pham Khanh Do-Cong, Crinò Stefano Francesco, Sundaram Sridhar, Repici Alessandro, Facciorusso Antonio, EUS International Group
Аннотация
METHODS: This was an international multicenter retrospective observational study at 28 tertiary-care centers. Outcomes were compared using propensity score matching (PSM). Clinical success was the primary outcome, with technical success, adverse event (AE) rate, and overall survival being the secondary outcomes.
RESULTS: Five hundred twenty-nine patients underwent EUS-guided drainage, of which 136 underwent EUS-GBD, and 393 underwent EUS-CDS. After 1-to-1 PSM, 112 patients per group were selected. EUS-GBD and EUS-CDS had similar technical success (97.3% and 91%; p = 0.08) and clinical success rates (83% and 85.7%; p = 0.17). AE rate was 19.6% in the EUS-GBD group and 12.5% in the EUS-CDS group (p = 0.20), of which 10 (8.9%) and 7 (6.2%) were severe AEs respectively (p = 0.61). Bleeding occurred in seven patients (6.1%) after EUS-GBD and three patients (2.5%) after EUS-CDS, whereas five infectious events were registered after EUS-GBD (4.4%) and four cases (3.5%) after EUS-CDS (p = 0.29). No treatment-related deaths were observed.
CONCLUSION: In patients with MDBO after failed ERCP, EUS-GBD or EUS-CDS were comparable with similar rates of efficacy and safety. EUS-GBD could represent an easy and safe option in MDBO patients without previous cholecystectomy and with a clear patency of the cystic duct.